668 related articles for article (PubMed ID: 33818592)
1. Reactogenicity Following Receipt of mRNA-Based COVID-19 Vaccines.
Chapin-Bardales J; Gee J; Myers T
JAMA; 2021 Jun; 325(21):2201-2202. PubMed ID: 33818592
[No Abstract] [Full Text] [Related]
2. Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.
Rojas-Pérez-Ezquerra P; Crespo Quirós J; Tornero Molina P; Baeza Ochoa de Ocáriz ML; Zubeldia Ortuño JM
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):180-181. PubMed ID: 33648905
[No Abstract] [Full Text] [Related]
3. Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?
Azenha Rama T; Álvarez-Twose I
J Investig Allergol Clin Immunol; 2021 Apr; 31(2):193-195. PubMed ID: 33574015
[No Abstract] [Full Text] [Related]
4. The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.
Ortega Rodríguez NR; Audícana Berasategui MT; de la Hoz Caballer B; Valero Santiago A
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):89-91. PubMed ID: 33393485
[No Abstract] [Full Text] [Related]
5. COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma.
Prieto PA; Mannava K; Sahasrabudhe DM
Lancet Oncol; 2021 Jun; 22(6):e281. PubMed ID: 34087152
[No Abstract] [Full Text] [Related]
6. Maintaining Safety with SARS-CoV-2 Vaccines.
Castells MC; Phillips EJ
N Engl J Med; 2021 Feb; 384(7):643-649. PubMed ID: 33378605
[No Abstract] [Full Text] [Related]
7. Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.
Soeiro T; Salvo F; Pariente A; Grandvuillemin A; Jonville-Béra AP; Micallef J
Therapie; 2021; 76(4):365-367. PubMed ID: 33858693
[No Abstract] [Full Text] [Related]
8. Successes of the CDC monitoring systems in evaluating post-authorization safety of COVID-19 vaccines.
Moro PL; McNeil MM
Expert Rev Vaccines; 2022 Mar; 21(3):281-284. PubMed ID: 34957900
[No Abstract] [Full Text] [Related]
9. How COVID unlocked the power of RNA vaccines.
Dolgin E
Nature; 2021 Jan; 589(7841):189-191. PubMed ID: 33437061
[No Abstract] [Full Text] [Related]
10. Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.
Moghimi SM
Mol Ther; 2021 Mar; 29(3):898-900. PubMed ID: 33571463
[No Abstract] [Full Text] [Related]
11. Audio Interview: Covid-19 Vaccines and Pregnancy - A Conversation with CDC Director Rochelle Walensky.
Rubin EJ; Baden LR; Walensky RP; Morrissey S
N Engl J Med; 2021 Apr; 384(16):e73. PubMed ID: 33882211
[No Abstract] [Full Text] [Related]
12. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine.
Zakaria Z; Sapiai NA; Ghani ARI
Acta Neurochir (Wien); 2021 Aug; 163(8):2359-2362. PubMed ID: 34101024
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine.
Zeng G
Lancet Microbe; 2022 Aug; 3(8):e561. PubMed ID: 35659883
[No Abstract] [Full Text] [Related]
14. Synthetic Messenger RNA-Based Vaccines: from Scorn to Hype.
Pascolo S
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572452
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 vaccination in Israel.
Muhsen K; Cohen D
Clin Microbiol Infect; 2021 Nov; 27(11):1570-1574. PubMed ID: 34384875
[No Abstract] [Full Text] [Related]
16. Prior SARS-CoV-2 infection increases reactogenicity after SARS-COV-2 mRNA vaccine and could delay the administration of the vaccine based on timing of infection.
Stellini R; Gianello R; Meloni A; Croce E; Materzanini P; Gomarasca W
Infection; 2022 Jun; 50(3):791-793. PubMed ID: 34855188
[No Abstract] [Full Text] [Related]
17. Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent.
Minocha PK; Better D; Singh RK; Hoque T
J Pediatr; 2021 Nov; 238():321-323. PubMed ID: 34166671
[No Abstract] [Full Text] [Related]
18. Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results.
Lombardi A; Bozzi G; Ungaro R; Villa S; Castelli V; Mangioni D; Muscatello A; Gori A; Bandera A
Front Immunol; 2021; 12():657711. PubMed ID: 33777055
[No Abstract] [Full Text] [Related]
19. Postvaccination anaphylaxis and mRNA-based SARS-CoV-2 vaccines-Much ado about nothing?
Marcec R; Likic R
Br J Clin Pharmacol; 2021 Sep; 87(9):3632-3633. PubMed ID: 33580602
[No Abstract] [Full Text] [Related]
20. Experts Discuss COVID-19-Vaccine Questions, School Openings, and More.
JAMA; 2021 Apr; 325(13):1244-1245. PubMed ID: 33729427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
